U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourcing), By Test Type, By End-use, By Sample (Sterile Drugs, Biologics & Therapeutics), And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1 Methodology And Scope
                   1.1.Market Segmentation & Scope
                       1.1.1.Type
                       1.1.2.Product Type
                       1.1.3.Test Type
                       1.1.4.Sample
                       1.1.5.End-Use
                       1.1.6.Regional Scope
                       1.1.7.Estimates And Forecast Timeline
                   1.2.Research Methodology
                   1.3.Information Procurement
                       1.3.1.Purchased Database
                       1.3.2.GVR’s Internal Database
                       1.3.3.Secondary Sources
                       1.3.4.Primary Research
                       1.3.5.Details Of Primary Research
                   1.4.Information Or Data Analysis
                       1.4.1.Data Analysis Models
                   1.5.Market Formulation & Validation
                   1.6.Model Details
                       1.6.1.Commodity Flow Analysis (Model 1)
                           1.6.1.1.Approach 1: Commodity Flow Approach
                       1.6.2.Volume Price Analysis (Model 2)
                           1.6.2.1.Approach 2: Volume Price Analysis
                   1.7.List Of Secondary Sources
                   1.8.List Of Primary Sources
                   1.9.Objectives
                       1.9.1.Objective 1
                       1.9.2.Objective 2
Chapter 2 Executive Summary
                   2.1.Market Outlook
Chapter 3 U.S. Pharmaceutical Sterility Testing Market Variables, Trends & Scope
                   3.1.Market Lineage Outlook
                       3.1.1.Parent Market Outlook
                       3.1.2.Related/Ancillary Market Outlook
                   3.2.Penetration & Growth Prospect Mapping
                   3.3.Market Dynamics
                       3.3.1.Market Driver Analysis
                           3.3.1.1.Supportive Government Investment In The Healthcare Industry
                           3.3.1.2.Increasing R&D Activities
                           3.3.1.3.Increasing Number Of Drug Launches
                           3.3.1.4.Increasing Focus On Quality And Sterility
                       3.3.2.Market Restraint Analysis
                           3.3.2.1.Third-Party Performance
                   3.4.U.S. Pharmaceutical Sterility Testing Market Analysis Tools
                       3.4.1.Porter’s Five Forces Analysis
                       3.4.2.PESTLE Analysis
                       3.4.3.Major Deals & Strategic Alliances Analysis
                           3.4.3.1.Mergers And Acquisition
                           3.4.3.2.Expansions
                           3.4.3.3.Agreements And Collaborations
                           3.4.3.4.Product And Service Launches
                   3.5.Covid-19 Impact And Reformation Strategy
Chapter 4 U.S. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis
                   4.1.Definitions And Scope
                   4.2.U.S. Pharmaceutical Sterility Testing Market Share, 2021 & 2030
                       4.2.1.In-House Pharmaceutical Sterility Testing
                           4.2.1.1.In-House Pharmaceutical Sterility Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
                       4.2.2.Outsourcing Pharmaceutical Sterility Testing
                           4.2.2.1.Outsourcing Pharmaceutical Sterility Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 5 U.S. Pharmaceutical Sterility Testing Market: Product Type Estimates & Trend Analysis
                   5.1.Definitions And Scope
                   5.2.U.S. Pharmaceutical Sterility Testing Market Share, 2021 & 2030
                       5.2.1.Kits And Reagents
                           5.2.1.1.Kits And Reagents Market Estimates And Forecast 2018 - 2030 (USD Million)
                       5.2.2.Instruments
                           5.2.2.1.Instruments Market Estimates And Forecast 2018 - 2030 (USD Million)
                       5.2.3.Service
                           5.2.3.1.Service Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 6 U.S. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis
                   6.1.Definitions And Scope
                   6.2. U.S. Pharmaceutical Sterility Testing Market Share, 2021 & 2030
                       6.2.1.Sterility Testing
                           6.2.1.1.Sterility Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
                           6.2.1.2.Membrane Filtration
                               6.2.1.2.1.Membrane Filtration Market Estimates And Forecast 2018 - 2030 (USD Million)
                           6.2.1.3.Direct Inoculation
                               6.2.1.3.1.Direct Inoculation Market Estimates And Forecast 2018 - 2030 (USD Million)
                           6.2.1.4.Product Flush
                               6.2.1.4.1.Product Flush Market Estimates And Forecast 2018 - 2030 (USD Million)
                       6.2.2.Bioburden Testing
                           6.2.2.1.Bioburden Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
                       6.2.3.Bacterial Endotoxin Testing
                           6.2.3.1.Bacterial Endotoxin Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 7 U.S. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis
                   7.1.Definitions And Scope
                   7.2.U.S. Pharmaceutical Sterility Testing Market Share, 2021 & 2030
                       7.2.1.Pharmaceuticals
                           7.2.1.1.Pharmaceuticals Market Estimates And Forecast 2018 - 2030 (USD Million)
                       7.2.2.Medical Devices
                           7.2.2.1.Medical Devices Market Estimates And Forecast 2018 - 2030 (USD Million)
                       7.2.3.Biopharmaceuticals
                           7.2.3.1.Biopharmaceuticals Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 8 U.S. Pharmaceutical Sterility Testing Market: End-Use Estimates & Trend Analysis
                   8.1.Definitions And Scope
                   8.2.U.S. Pharmaceutical Sterility Testing Market Share, 2021 & 2030
                       8.2.1.Compounding Pharmacies
                           8.2.1.1.Compounding Pharmacies Market Estimates And Forecast 2018 - 2030 (USD Million)
                       8.2.2.Medical Devices Companies
                           8.2.2.1.Medical Devices Companies Market Estimates And Forecast 2018 - 2030 (USD Million)
                       8.2.3.Pharmaceutical Companies
                           8.2.3.1.Pharmaceutical Companies Market Estimates And Forecast 2018 - 2030 (USD Million)
                       8.2.4.Others
                           8.2.4.1.Other Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
                   9.1.Recent Developments & Impact Analysis, By Key Market Participant
                   9.2.Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                   9.3.Participant Categorization
                       9.3.1.Innovators
                           9.3.1.1.STERIS
                           9.3.1.2.Boston Analytical
                           9.3.1.3.Charles River Laboratories
                           9.3.1.4.SGS SA
                   9.4.Vendor Landscape
                       9.4.1.List Of Key Service Providers
                       9.4.2.Market Differentiators
                       9.4.3.U.S. Pharmaceutical Sterility Testing Market Share Analysis
Chapter 10 Competitive Landscape
                   10.1.Company Profiles
                       10.1.1.SGS SA
                           10.1.1.1.Company Overview
                           10.1.1.2.Service Benchmarking
                           10.1.1.3.Strategic Initiatives
                       10.1.2.Laboratory Corporation of America Holdings
                           10.1.2.1.Company Overview
                           10.1.2.2.Financial Performance
                           10.1.2.3.Service Benchmarking
                           10.1.2.4.Strategic Initiatives
                       10.1.3.Boston Analytical
                           10.1.3.1.Company Overview
                           10.1.3.2.Financial Performance
                           10.1.3.3.Service Benchmarking
                           10.1.3.4.Strategic Initiatives
                       10.1.4. Charles River Laboratories
                           10.1.4.1.Company Overview
                           10.1.4.2.Financial Performance
                           10.1.4.3.Service Benchmarking
                           10.1.4.4.Strategic Initiatives
                       10.1.5.Pacific Biolabs
                           10.1.5.1.Company Overview
                           10.1.5.2.Financial Performance
                           10.1.5.3.Service Benchmarking
                           10.1.5.4.Strategic Initiatives
                       10.1.6.STERIS
                           10.1.6.1.Company Overview
                           10.1.6.2.Financial Performance
                           10.1.6.3.Service Benchmarking
                           10.1.6.4.Strategic Initiatives
                       10.1.7. Pace Analytical
                           10.1.7.1.Company Overview
                           10.1.7.2.Financial Performance
                           10.1.7.3.Service Benchmarking
                           10.1.7.4.Strategic Initiatives
                       10.1.8.Nelson Laboratories, LLC
                           10.1.8.1.Company Overview
                           10.1.8.2.Financial Performance
                           10.1.8.3.Service Benchmarking
                           10.1.8.4.Strategic Initiatives
                       10.1.9.Infinity Laboratories
                           10.1.9.1.Company Overview
                           10.1.9.2.Financial Performance
                           10.1.9.3.Service Benchmarking
                           10.1.9.4.Strategic Initiatives
                       10.1.10.Thermo Fisher Scientific, Inc.
                           10.1.10.1.Company Overview
                           10.1.10.2.Financial Performance
                           10.1.10.3.Service Benchmarking
                           10.1.10.4.Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume Price Analysis
Fig. 10 U.S. pharmaceutical sterility testing market snapshot (2021)
Fig. 11 U.S. pharmaceutical sterility testing market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 U.S. pharmaceutical sterility testing market type outlook: Segment dashboard
Fig. 18 U.S. pharmaceutical sterility testing market: Type movement analysis
Fig. 19 In-house U.S. pharmaceutical sterility testing market 2018 - 2030 (USD Million)
Fig. 20 Outsourcing U.S. pharmaceutical sterility testing market 2018 - 2030 (USD Million)
Fig. 21 U.S. pharmaceutical sterility testing market product type outlook: Segment dashboard
Fig. 22 U.S. pharmaceutical sterility testing market: Product type movement analysis
Fig. 23 Kits and Reagents market 2018 - 2030 (USD Million)
Fig. 24 Instruments market 2018 - 2030 (USD Million)
Fig. 25 Service testing market 2018 - 2030 (USD Million)
Fig. 26 U.S. pharmaceutical sterility testing market test type outlook: Segment dashboard
Fig. 27 U.S. pharmaceutical sterility testing market: Test type movement analysis
Fig. 28 Sterility testing market 2018 - 2030 (USD Million)
Fig. 29 Membrane Filtration market 2018 - 2030 (USD Million)
Fig. 30 Direct Inoculation market 2018 - 2030 (USD Million)
Fig. 31 Bioburden testing market 2018 - 2030 (USD Million)
Fig. 32 Bacterial endotoxin testing market 2018 - 2030 (USD Million)
Fig. 33 Container closure integrity testing market 2018 - 2030 (USD Million)
Fig. 34 Rapid micro test market 2018 - 2030 (USD Million)
Fig. 35 ATP bioluminescence market 2018 - 2030 (USD Million)
Fig. 36 Fluorescent labeling market 2018 - 2030 (USD Million)
Fig. 37 Electrical resistance market 2018 - 2030 (USD Million)
Fig. 38 Others market 2018 - 2030 (USD Million)
Fig. 39 Antimicrobial effectiveness testing market 2018 - 2030 (USD Million)
Fig. 40 U.S. pharmaceutical sterility testing market sample outlook: Segment dashboard
Fig. 41 U.S. pharmaceutical sterility testing market: Sample movement analysis
Fig. 42 Pharmaceuticals market 2018 - 2030 (USD Million)
Fig. 43 Medical devices market 2018 - 2030 (USD Million)
Fig. 44 Biopharmaceuticals market 2018 - 2030 (USD Million)
Fig. 45 U.S. pharmaceutical sterility testing market: Sample movement analysis
Fig. 46 U.S. pharmaceutical sterility testing market end-use outlook: Segment dashboard
Fig. 47 U.S. pharmaceutical sterility testing market: End-use movement analysis
Fig. 48 Compounding Pharmacies market 2018 - 2030 (USD Million)
Fig. 49 Medical devices companies market 2018 - 2030 (USD Million)
Fig. 50 Pharmaceutical companies market 2018 - 2030 (USD Million)
Fig. 51 Others market 2018 - 2030 (USD Million)